Prevalence of Metabolic Syndrome Among Patients with Psoriasis Treated with TNF Inhibitors and the Effects of Anti-TNF Therapy on Their Lipid Profile: A Prospective Cohort Study-Reference-Cited by-同舟云学术

Prevalence of Metabolic Syndrome Among Patients with Psoriasis Treated with TNF Inhibitors and the Effects of Anti-TNF Therapy on Their Lipid Profile: A Prospective Cohort Study

Published:2020-04-01 Issue:3 Volume:18 Page:154-160
ISSN:1540-4196
Container-title:Metabolic Syndrome and Related Disorders
language:en
Short-container-title:Metabolic Syndrome and Related Disorders

Author:

Botelho Karine Paschoal¹,Pontes Maria Araci de Andrade²,Rodrigues Carlos Ewerton Maia³,Freitas Max Victor Carioca⁴

Affiliation:

1. Department of Pathology, Federal University of Ceara, Fortaleza, Brazil.

2. Dona Libânia Dermatology Center, Fortaleza, Brazil.

3. University of Fortaleza and Federal University of Ceará, Fortaleza, Brazil.

4. University of Fortaleza, Fortaleza, Brazil.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/met.2019.0092

Reference41 articles.

1. Tumor necrosis factor-alpha and the cytokine network in psoriasis

2. Imunopatogênese da psoríase: revisando conceitos

3. Psoriasis and metabolic syndrome: A systematic review and meta-analysis of observational studies

4. Prevalence of Metabolic Syndrome in Patients with Psoriasis: A Population-Based Study in the United Kingdom

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Residual metabolic burden in young psoriasis patients successfully treated with biologics;2024-09-02

2. Epidemiology of lipid disturbances in psoriasis: An analysis of trends from 2006 to 2023;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2024-08

3. Metabolic Syndrome and Psoriasis: Pivotal Roles of Chronic Inflammation and Gut Microbiota;International Journal of Molecular Sciences;2024-07-25

4. Effects of tumor necrosis factor-alpha inhibitors on lipid profiles in patients with psoriasis: a systematic review and meta-analysis;Frontiers in Immunology;2024-03-04

5. Oral administration of punicalagin attenuates imiquimod‐induced psoriasis by reducing ROS generation and inflammation via MAPK/ERK and NF‐κB signaling pathways;Phytotherapy Research;2023-11-27